Events

Safety Alert for Kendall 1010P Multi-Function Defibrillation Electrodes & Medi-Trace Cadence Adult Multi-Function Defibrillation Electrodes

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by Covidien LLC.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2014-09-29
  • Event Date Posted
    2014-09-29
  • Event Country
    Hong Kong
  • Event Source
    DH
  • Event Source URL
    https://www.mdco.gov.hk/english/safety/recalls/recalls_20140929a.html
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Extra notes in the data
    Medical Device Safety Alert
  • Reason
    Medical device safety alert: covidien llc kendall 1010p multi-function defibrillation electrodes & medi-trace cadence adult multi-function defibrillation electrodes the australia therapeutic goods administration (tga) and the health canada posted medical device safety alerts concerning kendall 1010p multi-function defibrillation electrodes [model no.:22660pc, 22660r] & medi-trace cadence adult multi-function defibrillation electrodes [model no.: 40000006] manufactured by covidien llc. according to the medical device safety alerts, there was incompatibility between the philips automated external defibrillators (aed) models fr3 and frx defibrillators and covidien medi-trace cadence and kendall defibrillation electrodes. these electrodes will not connect with philips fr3 and frx aed units, and in the case of the use of covidien defibrillation electrodes with the philips fr3 aed units, could result in a delay of therapy. the frx aed unit requires the pads to be pre-connected, and will issue a continuous alarm chirp to alert the user that the proper pads are not connected to the unit prior to use. the manufacturer is modifying the labeling to clarify that use of the affected electrodes are incompatible with certain aed units. for details, please refer to the following health canada and tga websites: http://www.Healthycanadians.Gc.Ca/recall-alert-rappel-avis/hc-sc/2014/41547r-eng.Php http://www.Tga.Gov.Au/sara/arn-detail.Aspx?k=rc-2014-rn-01034-1 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 29 sep 2014.

Device

Kendall 1010P Multi-Function Defibrillation Electrodes & Medi-Trace Cadence Adult Multi-Function ...
  • Model / Serial
  • Product Classification
    Cardiovascular Devices
  • Product Description
    Medical Device Safety Alert: Covidien LLC Kendall 1010P Multi-Function Defibrillation Electrodes & Medi-Trace Cadence Adult Multi-Function Defibrillation Electrodes
  • Manufacturer
    Covidien LLC

Manufacturer

Covidien LLC
  • Manufacturer Parent Company (2017)
    Medtronic plc
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DH